Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunities Sabine Häussermann transitions to newly created role of Chief Scientific Officer to drive company’s scientific evidence development initiatives Munich (Germany) and Boston, MA USA, February 18, 2025 – VisionHealth GmbH, a pioneer

VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation  DB Speciality Invest, an investment firm of Dr. Dietrich Bruchmann, invests in VisionHealth   Funds will be used for EU and U.S. regulatory approval and commercial launch

Nagarjun Anantha Padmanabha has been part of the VisionHealth team for four years. As Head of Software Development, he has a lot of responsibilities and a varied scope of duties. This includes, but is not limited to, organizing and leading development teams in the creation of software products, planning, scheduling,